Apoptosis Inhibitor 5 Increases Metastasis via Erk-mediated MMP expression.

BMB Rep 2015 Jun;48(6):330-5

Laboratory of Infection and Immunology, Graduate School of Medicine, Korea University, Ansan 425-707; Department of Biochemistry, Korea University College of Medicine, Seoul 136-705, Korea.

Apoptosis inhibitor 5 (API5) has recently been identified as a tumor metastasis-regulating gene in cervical cancer cells. However, the precise mechanism of action for API5 is poorly understood. Here, we show that API5 increases the metastatic capacity of cervical cancer cells in vitro and in vivo via up-regulation of MMP-9. Interestingly, API5-mediated metastasis was strongly dependent on the Erk signaling pathway. Conversely, knock-down of API5 via siRNA technology decreased the level of phospho-Erk, the activity of the MMPs, in vitro invasion, and in vivo pulmonary metastasis. Moreover, the Erk-mediated metastatic action was abolished by the mutation of leucine into arginine within the heptad leucine repeat region, which affects protein-protein interactions. Thus, API5 increases the metastatic capacity of tumor cells by up-regulating MMP levels via activation of the Erk signaling pathway.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578619PMC
http://dx.doi.org/10.5483/bmbrep.2015.48.6.139DOI Listing
June 2015
30 Reads
4 Citations
2.600 Impact Factor

Publication Analysis

Top Keywords

metastatic capacity
8
erk signaling
8
signaling pathway
8
increases metastatic
8
cancer cells
8
cervical cancer
8
metastasis erk-mediated
8
api5 increases
8
apoptosis inhibitor
8
api5
5
level phospho-erk
4
decreased level
4
technology decreased
4
activity mmps
4
vitro invasion
4
mmps vitro
4
sirna technology
4
phospho-erk activity
4
api5 sirna
4
mmp-9 interestingly
4

Similar Publications